{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:14:27Z","timestamp":1788574467899,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"DOI":"10.1007\/s12185-026-04271-6","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:00:11Z","timestamp":1788573611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fulminant hyperammonemia during intensive chemotherapy in the setting of previously unrecognized partial ornithine transcarbamylase deficiency"],"prefix":"10.1007","author":[{"given":"Risa","family":"Hashida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoichiro","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Itakusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyosuke","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Nakase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Nawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,5]]},"reference":[{"key":"4271_CR1","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/j.leukres.2009.01.008","volume":"33","author":"KH Metzeler","year":"2009","unstructured":"Metzeler KH, Boeck S, Christ B, Hausmann A, Stemmler HJ, Parhofer KG, et al. Idiopathic hyperammonemia (IHA) after dose-dense induction chemotherapy for acute myeloid leukemia: case report and review of the literature. Leuk Res. 2009;33:e69\u201372.","journal-title":"Leuk Res"},{"key":"4271_CR2","volume":"13","author":"M Fayed","year":"2021","unstructured":"Fayed M, Patel N, Al Turk Y, Bradley PB. Unexplained fatal hyperammonemia in a patient with new diagnosis of acute monoblastic leukemia. Cureus. 2021;13:e20108.","journal-title":"Cureus"},{"key":"4271_CR3","first-page":"1119","volume":"17","author":"SM Davies","year":"1996","unstructured":"Davies SM, Szabo E, Wagner JE, Ramsay NKC, Weisdorf DJ. Idiopathic hyperammonemia: a frequently lethal complication of bone marrow transplantation. Bone Marrow Transpl. 1996;17:1119\u201325.","journal-title":"Bone Marrow Transpl"},{"key":"4271_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1200\/JCO.1991.9.4.679","volume":"9","author":"WJ Baker","year":"1991","unstructured":"Baker WJ, Royer GL Jr, Weiss RB. Cytarabine and neurologic toxicity. J Clin Oncol. 1991;9:679\u201393.","journal-title":"J Clin Oncol"},{"key":"4271_CR5","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3174\/ajnr.A0928","volume":"29","author":"WS Bartynski","year":"2008","unstructured":"Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008;29:1036\u201342.","journal-title":"AJNR Am J Neuroradiol"},{"key":"4271_CR6","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3174\/ajnr.A2112","volume":"31","author":"AM McKinney","year":"2010","unstructured":"McKinney AM, Lohman BD, Sarikaya B, Uhlmann E, Spanbauer J, Singewald T, et al. Acute hepatic encephalopathy: diffusion-weighted and fluid-attenuated inversion recovery findings, and correlation with plasma ammonia level and clinical outcome. AJNR Am J Neuroradiol. 2010;31:1471\u20139.","journal-title":"AJNR Am J Neuroradiol"},{"key":"4271_CR7","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1016\/j.jceh.2014.02.004","volume":"5","author":"RF Butterworth","year":"2015","unstructured":"Butterworth RF. Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure. J Clin Exp Hepatol. 2015;5:S96\u2013103.","journal-title":"J Clin Exp Hepatol"},{"key":"4271_CR8","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062\u20137.","journal-title":"Nucleic Acids Res"},{"key":"4271_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1067\/mem.2003.6","volume":"41","author":"R Gaspari","year":"2003","unstructured":"Gaspari R, Arcangeli A, Mensi S, Schembri Wismayer D, Tartaglione T, Antuzzi D, et al. Late-onset presentation of ornithine transcarbamylase deficiency in a young woman with hyperammonemic coma. Ann Emerg Med. 2003;41:104\u20139.","journal-title":"Ann Emerg Med"},{"key":"4271_CR10","doi-asserted-by":"publisher","first-page":"2265187","DOI":"10.1080\/16078454.2023.2265187","volume":"28","author":"G Tsykunova","year":"2023","unstructured":"Tsykunova G, Kristensen E, Stray-Pedersen A, Bruserud \u00d8, Wiig S\u00f8rensen I, Bruserud \u00d8, et al. Adult presentation of ornithine transcarbamylase deficiency: a possible cause of hyperammonemia after high-dose chemotherapy and stem cell transplantation. Hematology. 2023;28:2265187.","journal-title":"Hematology"},{"key":"4271_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s13023-020-01606-2","volume":"15","author":"D Lu","year":"2020","unstructured":"Lu D, Han F, Qiu W, Zhang H, Ye J, Liang L, et al. Clinical and molecular characteristics of 69 Chinese patients with ornithine transcarbamylase deficiency. Orphanet J Rare Dis. 2020;15:340.","journal-title":"Orphanet J Rare Dis"},{"key":"4271_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s100380050037","volume":"43","author":"T Kogo","year":"1998","unstructured":"Kogo T, Satoh Y, Kanazawa M, Yamamoto S, Takayanagi M, Ohtake A, et al. Expression analysis of two mutant human ornithine transcarbamylases in COS-7 cells. J Hum Genet. 1998;43:54\u20138.","journal-title":"J Hum Genet"},{"key":"4271_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12839","volume":"20","author":"R Graetz","year":"2018","unstructured":"Graetz R, Meyer R, Shehab K, Katsanis E. Successful resolution of hyperammonemia following hematopoietic cell transplantation with directed treatment of Ureaplasma parvum infection. Transpl Infect Dis. 2018;20:e12839.","journal-title":"Transpl Infect Dis"},{"key":"4271_CR14","doi-asserted-by":"crossref","unstructured":"Nowbakht C, Edwards AR, Rodriguez-Buritica DF, Luce AM, Doshi PB, De Golovine A, et al. Two cases of fatal hyperammonemia syndrome due to Mycoplasma hominis and Ureaplasma urealyticum in immunocompromised patients outside lung transplant recipients. Open Forum Infect Dis. 2019;6:ofz033.","DOI":"10.1093\/ofid\/ofz033"},{"key":"4271_CR15","first-page":"390","volume":"24","author":"J Takanashi","year":"2003","unstructured":"Takanashi J, Barkovich AJ, Cheng SF, Kostiner D, Baker JC, Packman S. Brain MR imaging in acute hyperammonemic encephalopathy arising from late-onset ornithine transcarbamylase deficiency. AJNR Am J Neuroradiol. 2003;24:390\u20133.","journal-title":"AJNR Am J Neuroradiol"},{"key":"4271_CR16","doi-asserted-by":"crossref","unstructured":"U-King-Im JM, Yu E, Bartlett E, Soobrah R, Kucharczyk W. Acute hyperammonemic encephalopathy in adults: imaging findings. AJNR Am J Neuroradiol. 2011;32:413\u2013418.","DOI":"10.3174\/ajnr.A2290"},{"key":"4271_CR17","unstructured":"Lichter-Konecki U, Caldovic L, Morizono H, Simpson K, Ah Mew N, MacLeod E. Ornithine transcarbamylase deficiency. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132026."},{"key":"4271_CR18","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.amjmed.2010.02.029","volume":"123","author":"JN LaBuzetta","year":"2010","unstructured":"LaBuzetta JN, Yao JZ, Bourque DL, Zivin J. Adult nonhepatic hyperammonemia: a case report and differential diagnosis. Am J Med. 2010;123:885\u201391.","journal-title":"Am J Med"},{"key":"4271_CR19","doi-asserted-by":"publisher","first-page":"e897","DOI":"10.1097\/CCM.0000000000003278","volume":"46","author":"A Sakusic","year":"2018","unstructured":"Sakusic A, Sabov M, McCambridge AJ, Rabinstein AA, Singh TD, Mukesh K, et al. Features of adult hyperammonemia not due to liver failure in the intensive care unit. Crit Care Med. 2018;46:e897\u2013903.","journal-title":"Crit Care Med"},{"key":"4271_CR20","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1378\/chest.06-2940","volume":"132","author":"AS Clay","year":"2007","unstructured":"Clay AS, Hainline BE. Hyperammonemia in the ICU. Chest. 2007;132:1368\u201378.","journal-title":"Chest"},{"key":"4271_CR21","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/jimd.12100","volume":"42","author":"J H\u00e4berle","year":"2019","unstructured":"H\u00e4berle J, Burlina A, Chakrapani A, Dixon M, Karall D, Lindner M, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision. J Inherit Metab Dis. 2019;42:1192\u2013230.","journal-title":"J Inherit Metab Dis"},{"key":"4271_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2025.109223","volume":"146","author":"J Maquet","year":"2025","unstructured":"Maquet J, Pontoizeau C, Imbard A, Gobin-Limballe S, Arnoux JB, Le Guillou \u00c9, et al. Clinical, biochemical, and molecular findings in adults with hyperammonemia: a French bi-centric retrospective study. Mol Genet Metab. 2025;146:109223.","journal-title":"Mol Genet Metab"},{"key":"4271_CR23","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S0002-9343(88)80239-0","volume":"85","author":"RB Mitchell","year":"1988","unstructured":"Mitchell RB, Wagner JE, Karp JE, Watson AJ, Brusilow SW, Przepiorka D, et al. Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. Am J Med. 1988;85:662\u20137.","journal-title":"Am J Med"},{"key":"4271_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/ajh.2830380213","volume":"38","author":"N Tse","year":"1991","unstructured":"Tse N, Cederbaum S, Glaspy JA. Hyperammonemia following allogeneic bone marrow transplantation. Am J Hematol. 1991;38:140\u20131.","journal-title":"Am J Hematol"},{"key":"4271_CR25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/sj.bmt.1702485","volume":"26","author":"P Frere","year":"2000","unstructured":"Frere P, Canivet JL, Gennigens C, Rebeix JP, Fillet G, Beguin Y. Hyperammonemia after high-dose chemotherapy and stem cell transplantation. Bone Marrow Transpl. 2000;26:343\u20135.","journal-title":"Bone Marrow Transpl"},{"key":"4271_CR26","first-page":"3136074","volume":"2020","author":"C Angelo","year":"2020","unstructured":"Angelo C, Vincent MF, Komuta M, Hantson P, Straetmans N, Boulet E. Fatal idiopathic hyperammonemia after induction chemotherapy for acute myeloid leukemia. Case Rep Hematol. 2020;2020:3136074.","journal-title":"Case Rep Hematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04271-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04271-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04271-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:00:13Z","timestamp":1788573613000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-026-04271-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,5]]},"references-count":26,"alternative-id":["4271"],"URL":"https:\/\/doi.org\/10.1007\/s12185-026-04271-6","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,5]]},"assertion":[{"value":"2 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare there is no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board (approval no. 07\u201344), and informed consent for publication was obtained from the patient\u2019s family.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}